NMS-P715
NMS-P715 is a selective, ATP-competitive inhibitor of MPS1, with an IC50 of 182 nM.
Product Specifications
CAS Number
1202055-32-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Mps1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NMS-P715.html
Purity
99.30
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C)C2=C1CCC3=C2N=C(NC4=CC=C(C(NC5CCN(CC5)C)=O)C=C4OC(F)(F)F)N=C3)NC6=C(CC)C=CC=C6CC
Molecular Formula
C35H39F3N8O3
Molecular Weight
676.73
Precautions
H302, H315, H319, H335
References & Citations
[1]Colombo R, et al. Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. Cancer Res. 2010 Dec 15;70 (24) :10255-64.|[2]Slee RB, et al. Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715. Mol Cancer Ther. 2014 Feb;13 (2) :307-315.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP51324PU-N 400 µL
Desmoglein 3 (DSG3) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC472171-500 1x 500 µL
Human Kappa Light Chain (B-Cell Marker) (rKLC264), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details